Mark G. Foletta - 21 Apr 2023 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Role
Director
Signature
/s/ Denise L. Jackson, as Attorney-in-Fact on behalf of Mark G. Foletta
Issuer symbol
AMN
Transactions as of
21 Apr 2023
Net transactions value
-$129,441
Form type
4
Filing time
25 Apr 2023, 18:05:50 UTC
Previous filing
13 Apr 2023
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMN Common Stock Options Exercise $0 +1,458 +18% $0.000000 9,531 21 Apr 2023 Direct F1
transaction AMN Common Stock Sale $129,441 -1,458 -15% $88.78 8,073 21 Apr 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMN Restricted Stock Units Options Exercise $0 -1,458 -100% $0.000000* 0 21 Apr 2023 Common Stock 1,458 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").
F2 The sale of 1,458 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The price reported in this row represents a weighted average price of $88.78 per share. These shares were sold in multiple transactions at prices ranging from $88.43 to $89.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4 The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.
F5 The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023.
F6 RSUs do not have an expiration date.